de Neeling A J, Rutgers A, Schot C S, Stobberingh E E
Laboratory for Chemotherapy, National Institute of Public Health and Environmental Protection, Bilthoven, The Netherlands.
J Antimicrob Chemother. 1988 Nov;22(5):613-21. doi: 10.1093/jac/22.5.613.
Mutants with increased resistance were selected from a clinical isolate of Pseudomonas aeruginosa using ceftazidime, piperacillin and carbenicillin. The MICs of these antibiotics and of ticarcillin were determined for the parent strain and for the selected mutants. Subsequently, cell-free extracts of the strains were prepared and the rates of hydrolysis of several beta-lactam substrates by the extracts were determined by HPLC procedures. It appeared possible to determine beta-lactamase activities in the crude cell extracts at the low substrate concentrations which may be attainable in the periplasm of Gram-negative bacteria. It is concluded that the increased drug MICs for mutants selected with ceftazidime or piperacillin, but not for those selected with carbenicillin, were caused by increased chromosomal beta-lactamase activity.
使用头孢他啶、哌拉西林和羧苄西林从铜绿假单胞菌的临床分离株中筛选出耐药性增强的突变体。测定了这些抗生素以及替卡西林对亲本菌株和所选突变体的最低抑菌浓度(MIC)。随后,制备了菌株的无细胞提取物,并通过高效液相色谱法(HPLC)测定了提取物对几种β-内酰胺底物的水解速率。发现在革兰氏阴性菌周质中可能达到的低底物浓度下,能够在粗细胞提取物中测定β-内酰胺酶活性。得出的结论是,用头孢他啶或哌拉西林筛选出的突变体药物MIC增加,而用羧苄西林筛选出的突变体则没有,这是由于染色体β-内酰胺酶活性增加所致。